Publication | Closed Access

Selenium supplementation, soluble tumor necrosis factor-α receptor type 1, and C-reactive protein during psoriasis therapy with narrowband ultraviolet B

InflammationMedicinePsoriasis TherapyImmunologySelenium SupplementationClinical DermatologyDermatologyPsoriatic ArthritisC-reactive Protein